FindTrial
Sign In

Novel coronavirus pneumonia (COVID-19): clinical pathological features and diagnostic system

Novel coronavirus pneumonia (COVID-19): clinical pathological characteristics and diagnostic system

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100047741
Enrollment
Unknown
Registered
2021-06-25
Start date
2021-08-01
Completion date
Unknown
Last updated
2022-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel coronavirus pneumonia (COVID-19)

Interventions

Case series:None

Sponsors

The First Affiliated Hospital of Army Medical University, PLA
Lead Sponsor

Eligibility

Sex/Gender
All
Age
53 Years to 69 Years

Inclusion criteria

Inclusion criteria: Clinically diagnosed as COVID-19 died patients .

Exclusion criteria

Exclusion criteria: None.

Design outcomes

Primary

MeasureTime frame
pathological changes in the structure, function and other aspects of cells;pathological changes in the structure, function and other aspects of organs;—

Countries

China

Contacts

Public ContactBian Xiuwu

The First Affiliated Hospital of Army Medical University

bianxiuwu@236.net+86 13708373857

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026